Edwards asks FDA to extend patent for Sapien heart valve

03/8/2013 | MassDevice.com (Boston)

The FDA is reviewing Edwards Lifesciences' request to extend by 1,757 days the patent covering the company's Sapien transcatheter aortic valve implant, which was approved by the agency in November 2011. The agency will accept public comments on the patent extension request through April 23.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ